Options
Patent
Title
Heterocyclic compounds as BLT2 agonists and their medical use
Other Title
Heterocyclische Verbindungen als BLT2-Agonisten und deren medizinische Verwendung
Abstract
Herein, compounds of Formulae (I-a) and (II) that act as selective agonists of the leukotriene B4 receptor 2 (BLT2) receptor are presented. The invention pertains to these compounds, their synthesis, as well as their medical use, amongst others in the treatment of pain and inflammatory skin diseases such as psoriasis.
Inventor(s)
Hernández Olmos, Víctor
Steinhilber, Dieter
Weigert, Andreas
Patent Number
EP4545138 A1
Publication Date
April 30, 2025
Language
English